KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Short term Debt (2016 - 2025)

Historic Short term Debt for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Merck's Short term Debt fell 5538.27% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 5538.27%. This contributed to the annual value of $2.6 billion for FY2024, which is 9307.58% up from last year.
  • According to the latest figures from Q3 2025, Merck's Short term Debt is $1.4 billion, which was down 5538.27% from $1.4 billion recorded in Q2 2025.
  • Merck's Short term Debt's 5-year high stood at $7.3 billion during Q1 2021, with a 5-year trough of $887.0 million in Q3 2023.
  • Its 5-year average for Short term Debt is $2.5 billion, with a median of $2.5 billion in 2021.
  • In the last 5 years, Merck's Short term Debt tumbled by 8334.02% in 2022 and then surged by 25501.69% in 2024.
  • Over the past 5 years, Merck's Short term Debt (Quarter) stood at $2.4 billion in 2021, then dropped by 19.32% to $1.9 billion in 2022, then decreased by 29.5% to $1.4 billion in 2023, then skyrocketed by 93.08% to $2.6 billion in 2024, then plummeted by 46.96% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.